| Bioactivity | PKG inhibitor peptide TFA is an ATP-competitive inhibitor of cGMP-dependent protein kinase (PKG), with a Ki of 86 μM[1]. |
| Invitro | Summary of experiments showing that intracellular dialysis of postsynaptic cells with PKG inhibitor PKG inhibitor peptide TFA (1 mM) failed to alter the induction of long-term depression (CCh-LTD)[2]. |
| Name | PKG inhibitor peptide TFA |
| Sequence | Arg-Lys-Arg-Ala-Arg-Lys-Glu |
| Shortening | RKRARKE |
| Formula | C40H75F3N18O12 |
| Molar Mass | 1057.13 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
PKG inhibitor peptide TFA
CAS: F: C40H75F3N18O12 W: 1057.13
PKG inhibitor peptide TFA is an ATP-competitive inhibitor of cGMP-dependent protein kinase (PKG), with a Ki of 86 μM.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.